| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
37,030,000 |
| Market
Cap: |
3.80(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.21 - $105.87 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 17.6 |
| Insider 3/6 Months : 18.2 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Celcuity is a clinical-stage biotechnology company focused on developing potential molecularly targeted therapies that address the same cancer driver a CELsignia companion diagnostic can identify. CELsignia is able to analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from targeted therapies. The drug candidate Co. is developing internally is gedatolisib, a potent, small molecule dual inhibitor, administered intravenously, that targets all class I isoforms of PI3K and mammalian target of rapamycin.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
170,100 |
170,100 |
170,100 |
| Total Buy Value |
$0 |
$9,571,319 |
$9,571,319 |
$9,571,319 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
20,000 |
129,325 |
129,325 |
146,075 |
| Total Sell Value |
$1,985,220 |
$6,803,590 |
$6,803,590 |
$7,050,353 |
| Total People Sold |
2 |
2 |
2 |
2 |
| Total Sell Transactions |
3 |
5 |
5 |
14 |
| End Date |
2025-09-11 |
2025-06-10 |
2024-12-10 |
2023-12-11 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Buller Richard E |
|
– • – |
2025-12-05 |
4 |
S |
$105.34 |
$317,070 |
I/I |
(3,000) |
6,760 |
|
- |
|
| Buller Richard E |
|
– • – |
2025-12-05 |
4 |
OE |
$5.50 |
$16,500 |
I/I |
3,000 |
9,760 |
|
- |
|
| Furcht Leo |
|
– • – |
2025-12-04 |
4 |
OE |
$7.60 |
$1,900 |
D/D |
250 |
11,000 |
|
- |
|
| Buller Richard E |
|
– • – |
2025-12-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
500 |
6,760 |
|
- |
|
| Buller Richard E |
|
– • – |
2025-12-01 |
4 |
S |
$98.13 |
$107,948 |
I/I |
(1,100) |
7,260 |
|
-7% |
|
| Buller Richard E |
|
– • – |
2025-12-01 |
4 |
OE |
$14.83 |
$16,313 |
I/I |
1,100 |
8,360 |
|
- |
|
| Dalvey David |
|
– • – |
2025-11-21 |
4 |
AS |
$100.00 |
$1,500,017 |
I/I |
(15,000) |
110,000 |
|
8% |
|
| Buller Richard E |
|
– • – |
2025-11-20 |
4 |
S |
$96.73 |
$377,255 |
I/I |
(3,900) |
7,260 |
|
-12% |
|
| Buller Richard E |
|
– • – |
2025-11-20 |
4 |
OE |
$14.83 |
$57,837 |
I/I |
3,900 |
11,160 |
|
- |
|
| Buller Richard E |
|
– • – |
2025-11-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
500 |
7,260 |
|
- |
|
| Nigon Richard |
|
– • – |
2025-09-11 |
4 |
OE |
$7.56 |
$59,875 |
D/D |
7,917 |
109,010 |
|
- |
|
| Baker Julian |
|
– – • |
2025-09-08 |
4 |
B |
$56.22 |
$9,571,319 |
I/I |
170,100 |
7,211,484 |
0.01 |
69% |
|
| Sullivan Brian F |
Chief Executive Officer |
• • – |
2025-09-02 |
4 |
OE |
$8.05 |
$839,937 |
D/D |
104,340 |
1,370,199 |
|
- |
|
| Baker Julian |
|
– – • |
2025-08-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,745,692 |
|
165% |
|
| Dalvey David |
|
– • – |
2025-07-28 |
4 |
AS |
$43.30 |
$4,397,603 |
I/I |
(100,000) |
125,000 |
|
172% |
|
| Dalvey David |
|
– • – |
2025-07-28 |
4 |
AS |
$44.36 |
$420,767 |
D/D |
(9,325) |
0 |
|
172% |
|
| Buller Richard E |
|
– • – |
2025-05-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,079 |
7,760 |
|
- |
|
| Buller Richard E |
|
– • – |
2025-05-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,079 |
1,029 |
|
- |
|
| Buller Richard E |
|
– • – |
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
2,108 |
|
- |
|
| Sullivan Brian F |
Chief Executive Officer |
• • – |
2025-04-14 |
4 |
GA |
$0.00 |
$0 |
D/D |
8,155 |
1,265,859 |
|
- |
|
| Sullivan Brian F |
Chief Executive Officer |
• • – |
2025-04-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,155 |
0 |
|
- |
|
| Sullivan Brian F |
Chief Executive Officer |
• • – |
2025-03-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
36,845 |
802,742 |
|
- |
|
| Sullivan Brian F |
Chief Executive Officer |
• • – |
2025-03-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
36,845 |
8,155 |
|
- |
|
| Sullivan Brian F |
Chief Executive Officer |
• • – |
2025-03-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
84,670 |
45,000 |
|
- |
|
| Sullivan Brian F |
Chief Executive Officer |
• • – |
2025-03-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
84,670 |
1,257,704 |
|
- |
|
91 Records found
|
|
Page 1 of 4 |
|
|
1.32 (1.27%) 
